Perception of castration value over cost in the metastatic prostate cancer scenario: a contemporary pharmacoeconomic perspective
Saved in:
Main Authors: | Col,Luciana Saboya Brito Dal, Andrade,Danilo L., Gon,Lucas M., Capibaribe,Diego M., Amaro,Marcelo P., Truzzi,Natássia C. C., Malkomes,Barbara R., Reis,Leonardo O. |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Sociedade Brasileira de Urologia
2022
|
Online Access: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1677-55382022000100175 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
National Consensus on Non-metastatic Castration-Resistant Prostate Cancer: more than just a snapshot
by: Reis,Leonardo Oliveira, et al.
Published: (2021) -
Low-dose diethylstilbestrol for heavily pretreated metastatic castration-resistant prostate cancer
by: Verduzco-Aguirre,Haydeé C., et al.
Published: (2022) -
Overall survival prediction in metastatic castration-resistant prostate cancer treated with radium-223
by: Vidal,Monica, et al.
Published: (2020) -
Bone scan positivity in non-metastatic, castrate-resistant prostate cancer: external validation study
by: Johnston,Ashley W., et al.
Published: (2020) -
Costs of managing castrate-resistant metastatic prostate cancer patients at Inkosi Albert Luthuli Central Hospital
by: Gabela,NC, et al.
Published: (2021)